FR2378859A1 - - Google Patents

Info

Publication number
FR2378859A1
FR2378859A1 FR7802215A FR7802215A FR2378859A1 FR 2378859 A1 FR2378859 A1 FR 2378859A1 FR 7802215 A FR7802215 A FR 7802215A FR 7802215 A FR7802215 A FR 7802215A FR 2378859 A1 FR2378859 A1 FR 2378859A1
Authority
FR
France
Prior art keywords
new
strain
vaccines
rabies
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7802215A
Other languages
English (en)
French (fr)
Other versions
FR2378859B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of FR2378859A1 publication Critical patent/FR2378859A1/fr
Application granted granted Critical
Publication of FR2378859B1 publication Critical patent/FR2378859B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
FR7802215A 1977-01-26 1978-01-26 Expired FR2378859B1 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3258/77A GB1596653A (en) 1977-01-26 1977-01-26 Vaccine

Publications (2)

Publication Number Publication Date
FR2378859A1 true FR2378859A1 (OSRAM) 1978-08-25
FR2378859B1 FR2378859B1 (OSRAM) 1980-08-29

Family

ID=9754946

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7802215A Expired FR2378859B1 (OSRAM) 1977-01-26 1978-01-26

Country Status (20)

Country Link
US (2) US4320115A (OSRAM)
JP (2) JPS5394084A (OSRAM)
AT (1) AT368005B (OSRAM)
BE (1) BE863368A (OSRAM)
CA (1) CA1112167A (OSRAM)
CH (2) CH658192A5 (OSRAM)
DE (1) DE2803240B2 (OSRAM)
DK (1) DK36378A (OSRAM)
ES (2) ES466359A1 (OSRAM)
FI (1) FI59812C (OSRAM)
FR (1) FR2378859B1 (OSRAM)
GB (1) GB1596653A (OSRAM)
IE (1) IE46498B1 (OSRAM)
IT (1) IT1192756B (OSRAM)
LU (1) LU78951A1 (OSRAM)
NL (1) NL174371C (OSRAM)
NO (1) NO780156L (OSRAM)
PT (1) PT67554B (OSRAM)
SE (2) SE444453B (OSRAM)
ZA (1) ZA78421B (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100752A3 (de) * 1982-08-04 1985-04-17 Veterinär-Bakteriologisches Institut der Universität Bern Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung
EP0210552A3 (en) * 1985-07-26 1989-03-22 Behringwerke Aktiengesellschaft Live rabies vaccine

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347239A (en) 1980-07-30 1982-08-31 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
US4429045A (en) 1980-07-30 1984-01-31 Norden Laboratories, Inc. Rabies virus adapted for growth in swine testicle cell culture
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
CA1249518A (en) * 1985-09-06 1989-01-31 David Johnston Oral immunization of mammals
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
AU2359195A (en) * 1994-04-19 1995-11-10 Thomas Jefferson University Viral ribonucleocapsid as an immunological enhancer
US6495360B1 (en) * 1999-05-28 2002-12-17 Photogen, Inc. Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
US20030118628A1 (en) * 2001-04-05 2003-06-26 Tutuncu Nurhan Pinar Confectionery product having a salivation region and an oral comfort region
RU2402348C1 (ru) * 2009-05-13 2010-10-27 Государственное научное учреждение Всероссийский научно-исследовательский и технологический институт биологической промышленности РАСХН Вакцина антирабическая сухая для крупного и мелкого рогатого скота
CN112342185B (zh) * 2020-11-11 2022-12-02 深圳市卫光生物制品股份有限公司 一种鸡胚细胞狂犬病病毒的生物反应器工艺

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1567869A (OSRAM) * 1967-06-22 1969-05-23

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1015262A (en) * 1962-02-09 1965-12-31 Nat Res Dev Virus culture
US3255080A (en) * 1962-08-06 1966-06-07 Dow Chemical Co Live rabies virus vaccine and method for the production thereof
US3397267A (en) * 1964-09-21 1968-08-13 Research Corp Method of producing rabies vaccine
US4014991A (en) * 1976-01-23 1977-03-29 The United States Of America As Represented By The Department Of Health, Education And Welfare Oral rabies immunization of carnivores

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1567869A (OSRAM) * 1967-06-22 1969-05-23

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100752A3 (de) * 1982-08-04 1985-04-17 Veterinär-Bakteriologisches Institut der Universität Bern Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung
EP0210552A3 (en) * 1985-07-26 1989-03-22 Behringwerke Aktiengesellschaft Live rabies vaccine

Also Published As

Publication number Publication date
US4400472A (en) 1983-08-23
FI59812C (fi) 1981-10-12
JPS6225127B2 (OSRAM) 1987-06-01
SE8201768L (sv) 1982-03-19
DK36378A (da) 1978-07-27
PT67554B (en) 1979-06-18
DE2803240B2 (de) 1980-08-07
IE780161L (en) 1978-07-26
BE863368A (fr) 1978-07-26
NO780156L (no) 1978-07-27
IT1192756B (it) 1988-05-04
CA1112167A (en) 1981-11-10
NL7800708A (nl) 1978-07-28
AT368005B (de) 1982-08-25
US4320115A (en) 1982-03-16
PT67554A (en) 1978-02-01
JPS5877822A (ja) 1983-05-11
ES469937A1 (es) 1978-12-16
GB1596653A (en) 1981-08-26
CH658192A5 (de) 1986-10-31
SE444453B (sv) 1986-04-14
SE443924B (sv) 1986-03-17
FI780184A7 (fi) 1978-07-27
FR2378859B1 (OSRAM) 1980-08-29
SE7800781L (sv) 1978-07-27
JPS637754B2 (OSRAM) 1988-02-18
ES466359A1 (es) 1978-10-01
ZA78421B (en) 1979-01-31
CH659084A5 (de) 1986-12-31
JPS5394084A (en) 1978-08-17
LU78951A1 (fr) 1979-09-06
DE2803240A1 (de) 1978-08-10
IE46498B1 (en) 1983-06-29
NL174371C (nl) 1984-06-01
ATA52678A (de) 1982-01-15
IT7867143A0 (it) 1978-01-25
FI59812B (fi) 1981-06-30

Similar Documents

Publication Publication Date Title
FR2378859A1 (OSRAM)
US5997881A (en) Method of making non-pyrogenic lipopolysaccharide or A
ES2270416T3 (es) Vector nucleotidico, composicion que lo contiene y vacuna para la inmunizacion contra la hepatitis.
AU655823B2 (en) Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
EP0827410B1 (en) Method for introducing and expressing genes in animal cells
RO116459B1 (ro) Compozitie imunogena
YU57702A (sh) Novi postupak za deregulaciju amiloida
NO975434L (no) Fremgangsmåte for fremstilling av influensa hemagglutinin multivalente vaksiner
KR20070041765A (ko) Ｈｉｖ-감염의 예방 및 치료를 위한 백신
ES2144426T3 (es) Terapia genica linfoquimica del cancer en combinacion con antigenos tumorales.
DE59006080D1 (de) Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum.
Schetters et al. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens
Dominici et al. Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL
FR2382500A1 (fr) Nouveaux vaccins aviaires et procede pour leur preparation
ATE375T1 (de) Grippevirusimpfstoff und verfahren zu seiner herstellung.
Simonsen et al. Fall‐off in immunity following diphtheria revaccination‐an 8 year follow‐up study
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
US6066623A (en) Polynucleotide vaccine protective against malaria, methods of protection and vector for delivering polynucleotide vaccines
Birx et al. HIV vaccine therapy
FR2589063B1 (fr) Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
Brookes et al. Generation of diversity in the hierarchy of T-cell epitope responses following different routes of immunization with simian immunodeficiency virus protein
Coursaget et al. Clinical trial of hepatitis B vaccine in a simplified immunization programme
WO2001030989A3 (en) Method for creating divergent populations of nucleic acid molecules and proteins
US20030175693A1 (en) HIV recombinant vaccine
FR2598621B1 (fr) Nouvelle fraction antigenique obtenue par liberation dans un milieu de culture de vibrions choleriques, procede de preparation d'une telle fraction et son application a la preparation d'un vaccin cholerique oral

Legal Events

Date Code Title Description
ST Notification of lapse